SocialyTime SocialyTime
Rezultatele cautarii
Vedeti tot
  • Conecteaza-te
    Conecteaza-te
    Inscrie-te
    Căutare
    Night Mode

Căutare

Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni

  • News Feed
  • EXPLORE
  • Pagini
  • Grupuri
  • Events
  • Blogs
  • Offers
  • Jobs
  • Courses
  • Postari
  • Blogs
  • Utilizatori
  • Pagini
  • Grupuri
  • Events
  • Deng Yue a adăugat un sunet Fitness
    2026-01-13 09:57:35 -
    Say goodbye to the era of "high doses"! How does Tenofovir Amibufenamide achieve highly effective antiviral effects with only 1/10 of the dose?
    01/13/2026 Written by DengyueMed Tenofovir Amibufenamide (Hengmu®) is a next-generation tenofovir prodrug independently developed in China for the treatment of chronic hepatitis B (CHB). Designed with optimized molecular structure and enhanced liver targeting, Tenofovir Amibufenamide delivers potent antiviral efficacy at a significantly lower dose, while offering a favorable long-term...
    0 Commentarii 0 Distribuiri 345 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Shweta Kadam a adăugat un sunet Alte
    2025-12-16 11:07:19 -
    Eastern Equine Encephalitis Market Size, Analysis, Scope, Demand, Opportunities, Statistics
    "Executive Summary Eastern Equine Encephalitis Market Size and Share Forecast The global eastern equine encephalitis market size was valued at USD 150.5 billion in 2025 and is expected to reach USD 391.67 billion by 2033, at a CAGR of 12.70 % during the forecast period. All the data and information involved in this Eastern Equine Encephalitis report has...
    0 Commentarii 0 Distribuiri 747 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Amit Sharma a adăugat un sunet Alte
    2025-12-04 13:03:06 -
    Remdesivir Production Cost Analysis Report by Procurement Resource
    Procurement Resource, a leading name in procurement intelligence and market research, is pleased to release its latest Remdesivir Production Cost Report. This detailed report is a crucial tool for pharmaceutical companies, active pharmaceutical ingredient (API) manufacturers, investors, and regulatory stakeholders seeking to gain a deep understanding of the economics, technologies, and market...
    0 Commentarii 0 Distribuiri 547 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
© 2026 SocialyTime Romaian
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Termeni Confidențialitate Contacteaza-ne Director